Perimeter Medical Imaging AI to Report Q3 Results
The commercial-stage medical technology company will release third quarter 2026 financial and operating results before market open on November 24, 2026.
Updated on Nov. 18, 2026 in Corporate Finance

Perimeter Medical Imaging AI will report its third quarter 2026 financial and operating results before market open on November 24, 2026. The company will host a webcast and conference call that morning at 8:30 a.m. Eastern Time.
Why it matters
Quarterly results and management commentary give investors and observers a regular update on the company's operating performance. The company's Claire OCT System, which has FDA approval for evaluating lumpectomy tissue margins in breast cancer patients, is part of the commercial business these results will reflect.
The earnings release is scheduled for November 24, 2026, before market open, with the conference call beginning at 8:30 a.m. Eastern Time. No specific financial figures have yet been published, and the quarter's results remain unreported.
The players
Perimeter Medical Imaging AI, Inc.
A commercial-stage medical technology company headquartered in Toronto, Canada, with a Dallas, Texas location, that develops imaging systems including the Claire OCT System for use in breast cancer surgery.
The details
Perimeter Medical Imaging AI, Inc. plans to release its third quarter 2026 financial and operating results before market open on November 24, 2026. Management will discuss the results on a live webcast and conference call that day, which will be archived on the company's website. Dial-in numbers are 1-800-717-1738 for Canada and the United States, and 1-646-307-1865 for international callers.
Timeline
November 24, 2026, before market open: Release of third quarter 2026 financial and operating results.
November 24, 2026, 8:30 a.m. ET: Third quarter results conference call and webcast.
Market Dynamics
The quarterly report will provide a near-term check on commercial traction for the Claire OCT System, which the U.S. Food and Drug Administration has approved as an adjunctive tool for assessing margins of excised lumpectomy tissue in biopsy-confirmed breast cancer. Its results will show how that FDA clearance is translating into revenue for a company still in the commercial stage.
Shareholders and prospective investors will get the company's first look at third quarter 2026 performance on November 24, 2026, and can listen to the 8:30 a.m. Eastern Time call live or through the archived replay on the company's website. The call and release give investors a concrete point to reassess the company's commercial progress before making portfolio decisions.
The takeaway
Investors tracking Perimeter Medical Imaging AI should mark November 24, 2026 on their calendars and compare the reported quarterly figures against the company's prior performance and stated commercial goals. The live call and archived replay offer direct access to management's explanation of the results.
What happens next
Perimeter Medical Imaging AI will release its third quarter 2026 financial and operating results before market open on November 24, 2026, followed by a conference call at 8:30 a.m. Eastern Time that day.
Further reading
For more on how publicly traded companies report and discuss their results, browse our Corporate Finance coverage.
Source note: This article includes information reported by Star Local.






